UK Flag
de flag
French Flag
Dutch Flag
  +44 20 7660 1406

Category: CIK: News, Information & Studies

Response rate with DCTs

Combining chemotherapy with adoptive cellular therapy

This study examined a combination of dendritic cell (DC) therapy and cytokine-induced killer (CIK) cells with high-dose chemotherapy (HDC) for metastatic breast cancer (MBC) patients.
Results of the treatment

Cytolytic Immunity of CIK cells upon Coculture with Mature Dendritic Cells

Cum Survival

Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer

Survival Time

Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study

Duration of Chemotherapy

Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection

CIK Treatment

Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine- induced killer cells in 294 patients

Get In Touch